These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 7505215)

  • 1. Parenterally transmitted hepatitis: viruses, vaccines, and antiviral therapy.
    Chung RT; Kaplan LM
    Compr Ther; 1993; 19(4):163-73. PubMed ID: 7505215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of hepatitis B, C, and delta virus infections among children in Mongolia: progress in childhood immunization.
    Tsatsralt-Od B; Takahashi M; Endo K; Agiimaa D; Buyankhuu O; Ninomiya M; Lorenzo FR; Okamoto H
    J Med Virol; 2007 Aug; 79(8):1064-74. PubMed ID: 17596839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The epidemiology of viral hepatitis in the United States.
    Alter MJ; Mast EE
    Gastroenterol Clin North Am; 1994 Sep; 23(3):437-55. PubMed ID: 7989088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Score: hepatitis viruses 5, vaccines 1. Researchers believe sixth virus exists.
    Russell B
    Am Nurse; 1992 Sep; 24(8):1, 11. PubMed ID: 1387770
    [No Abstract]   [Full Text] [Related]  

  • 5. The epidemiology of hepatitis viruses B, C, and D.
    London WT; Evans AA
    Clin Lab Med; 1996 Jun; 16(2):251-71. PubMed ID: 8792071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Transmission and prevention of viral hepatitis].
    Pascal JP
    Rev Prat; 1995 Jan; 45(2):174-9. PubMed ID: 7725018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Transmission of viruses (from A to E) and prevention].
    Jouanolle H; Brissot P
    Rev Prat; 1990 Jun; 40(18):1660-6. PubMed ID: 2115202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B and C viruses: molecular identification and targeted antiviral therapies.
    Berenguer M; Wright TL
    Proc Assoc Am Physicians; 1998; 110(2):98-112. PubMed ID: 9542765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in hepatitis D virus biology and disease.
    Smedile A; Rizzetto M; Gerin JL
    Prog Liver Dis; 1994; 12():157-75. PubMed ID: 7746872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Basic and clinical aspects of hepatitis virus carriers].
    Shimoyama R; Sekiguchi S
    Hokkaido Igaku Zasshi; 1996 Jul; 71(4):427-48. PubMed ID: 8809569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B virus: old, new and future approaches to antiviral treatment.
    Karayiannis P
    J Antimicrob Chemother; 2003 Apr; 51(4):761-85. PubMed ID: 12654750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular epidemiological and clinical aspects of hepatitis D virus in a unique triple hepatitis viruses (B, C, D) endemic community in Taiwan.
    Lu SN; Chen TM; Lee CM; Wang JH; Tung HD; Wu JC
    J Med Virol; 2003 May; 70(1):74-80. PubMed ID: 12629646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis Part II. Viral hepatitis B, C, and D.
    Gurevich I
    Heart Lung; 1993; 22(5):450-6; quiz 457-8. PubMed ID: 8226010
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatitis B and hepatitis C in 2009.
    Marcellin P
    Liver Int; 2009 Jan; 29 Suppl 1():1-8. PubMed ID: 19207959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis vaccination among drug users.
    Quaglio G; Lugoboni F; Mezzelani P; Des Jarlais DC; Lechi A
    Vaccine; 2006 Apr; 24(15):2702-9. PubMed ID: 16436307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health care-associated transmission of hepatitis B and C viruses in hemodialysis units.
    Fabrizi F; Martin P
    Clin Liver Dis; 2010 Feb; 14(1):49-60; viii. PubMed ID: 20123439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New therapeutic options for hepatitis C.
    Waters L; Nelson M
    Curr Opin Infect Dis; 2006 Dec; 19(6):615-22. PubMed ID: 17075339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia.
    Tsatsralt-Od B; Takahashi M; Nishizawa T; Endo K; Inoue J; Okamoto H
    J Med Virol; 2005 Dec; 77(4):491-9. PubMed ID: 16254981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hepatitis C virus life cycle as a target for new antiviral therapies.
    Pawlotsky JM; Chevaliez S; McHutchison JG
    Gastroenterology; 2007 May; 132(5):1979-98. PubMed ID: 17484890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV/Hepatitis B and C co-infection: pathogenic interactions, natural history and therapy.
    Chung RT; Kim AY; Polsky B
    Antivir Chem Chemother; 2001; 12 Suppl 1():73-91. PubMed ID: 11594692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.